Galena Biopharma pounded in wake of stock-scheme allegation

|About: Galena Biopharma, Inc. (GALE)|By:, SA News Editor

Galena Biopharma (GALE -16.4%) was roughed up today in the wake of an Adam Feuerstein article saying promotional firm DreamTeamGroup undertook a brand promotion campaign on GALE's behalf that resembled "nonstandard" stock promotion schemes.

Feuerstein links the firm to two pieces removed from Seeking Alpha that were published in August and November 2013 and positive on Galena's prospects. The pieces were removed for violating SA terms of use -- despite coming from separate contributor accounts, they were written by the same person.

Galena was to present its corporate update this afternoon at the Leerink Global Healthcare Conference.

Shares regained some minimal ground after hours, +0.5%.